Contribution of peripheral IL-1beta expression in the systemic reactivation of focal MOG-EAE lesions in rat brain

Contribution of peripheral IL-1beta expression in the systemic reactivation of focal MOG-EAE lesions in rat brain

Mostrar outras versões (1)

Detalhes bibliográficos
Principais autores:	Serres, S, Anthony, D, Jiang, Y, Campbell, S, Merkler, D, Bruck, W, Recton, J, Sibson, N
Formato:	Conference item
Publicado em:	2009

Registros relacionados

CONTRIBUTION OF PERIPHERAL IL-1BETA EXPRESSION IN THE SYSTEMIC REACTIVATION OF FOCAL MOG-EAE LESIONS IN RAT BRAIN
por: Serres, S, et al.
Publicado em: (2009)

Reactivation of a focal EAE lesion by a systemic inflammatory response
por: Serres, S, et al.
Publicado em: (2007)

EAE Induction by Passive Transfer of MOG-specific CD4+ T Cells
por: Yuki Tanaka, et al.
Publicado em: (2017-07-01)

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis
por: Serres, S, et al.
Publicado em: (2013)

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
por: Serres, S, et al.
Publicado em: (2013)

ANTI-IL17 TREATMENT REDUCES CLINICAL SCORE AND VCAM-1 EXPRESSION IN EAE-ABH MICE DETECTED BY IN VIVO MAGNETIC RESONANCE IMAGING
por: Serres, S, et al.
Publicado em: (2009)

Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis
por: Aigner Ludwig, et al.
Publicado em: (2008-05-01)

Systemic inflammatory response reactivates immune-mediated lesions in rat brain.
por: Serres, S, et al.
Publicado em: (2009)

Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.
por: Mardiguian, S, et al.
Publicado em: (2013)

Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE.
por: Campbell, S, et al.
Publicado em: (2010)

Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated
por: Madrigal José LM, et al.
Publicado em: (2010-10-01)

Innate Signaling in the CNS Prevents Demyelination in a Focal EAE Model
por: Magdalena Dubik, et al.
Publicado em: (2021-06-01)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Y, et al.
Publicado em: (2019)

Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation
por: S. K. Vainio, et al.
Publicado em: (2022-02-01)

Peripheral nervous system involvement in MOG antibody-associated demyelination
por: Ramanathan, S, et al.
Publicado em: (2019)

Peripheral nervous system manifestations of MOG antibody associated disease
por: Pranjal Gupta, et al.
Publicado em: (2024-04-01)

Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice
por: Maria Erta, et al.
Publicado em: (2016-05-01)

Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
por: Ericsson-Dahlstrand Anders, et al.
Publicado em: (2007-05-01)

Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.
por: RuiRong Yuan, et al.
Publicado em: (2008-04-01)

Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
por: Wolfensohn, S, et al.
Publicado em: (2013)

Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders
por: Rinaldi, S, et al.
Publicado em: (2020)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Martin S. Weber, et al.
Publicado em: (2018-03-01)

Profiling the microRNA signature of the peripheral sensory ganglia in experimental autoimmune encephalomyelitis (EAE)
por: Timothy N. Friedman, et al.
Publicado em: (2019-11-01)

Proton MR spectroscopy in characterization of focal bone lesions of peripheral skeleton
por: Meenu Amar, et al.
Publicado em: (2019-12-01)

An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE
por: Joshua S. Stoolman, et al.
Publicado em: (2018-07-01)

Autoimmunity to astrocytes in multiple sclerosis and EAE
por: Amor, S, et al.
Publicado em: (2011)

Obesity Promotes EAE Through IL-6 and CCL-2-Mediated T Cells Infiltration
por: Zhe Ji, et al.
Publicado em: (2019-08-01)

Expression of IL-20 Receptor Subunit β Is Linked to EAE Neuropathology and CNS Neuroinflammation
por: Jacquelyn R. Dayton, et al.
Publicado em: (2021-09-01)

Anti-MOG associated myelitis
por: A. I. Isaykin, et al.
Publicado em: (2020-06-01)

Moffat MOdified Gravity (MOG)
por: Sreekanth Harikumar
Publicado em: (2022-04-01)

Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 Production
por: Sofia Fernanda Gonçalves Zorzella-Pezavento, et al.
Publicado em: (2013-01-01)

Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE
por: Hilary A. Seifert, et al.
Publicado em: (2019-10-01)

The Helminth Parasite Heligmosomoides polygyrus Attenuates EAE in an IL-4Rα-Dependent Manner
por: Madeleine P. J. White, et al.
Publicado em: (2020-09-01)

An approach to segmentation of a solid focal lesion in breast and its peripheral areas in ultrasound images
por: D.V. Pasynkov, et al.
Publicado em: (2023-06-01)

Characteristics of TSPO expression in marmoset EAE
por: Irene Falk, et al.
Publicado em: (2025-01-01)

Induction of NTPDase1/CD39 by Reactive Microglia and Macrophages Is Associated With the Functional State During EAE
por: Marija Jakovljevic, et al.
Publicado em: (2019-04-01)

Overexpression of GSN could decrease inflammation and apoptosis in EAE and may enhance vitamin D therapy on EAE/MS
por: Jifang Gao, et al.
Publicado em: (2017-04-01)

MOG-IgG1 antibodies in children
por: Waters, P, et al.
Publicado em: (2018)

Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease (Proceeding of the National Academy of Sciences of the United States of America (2009) 106, 1, (18-23) doi: 10.1073/pnas.0806787106)
por: Van Kasteren, S, et al.
Publicado em: (2009)

Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease.
por: van Kasteren, S, et al.
Publicado em: (2009)